(Q53245208)

English

Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.

scientific article published on 10 February 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography

1 reference

based on heuristic

inferred from title

Caroline Bodet-Milin

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Pierre-Yves Le Roux

object named as

Pierre-Yves Le Roux

1

0 references

author name string

Thomas Gastinne

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Steven Le Gouill

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Emmanuel Nowak

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Solène Querellou

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Beatrice Mahe

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Viviane Dubruille

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Nicolas Blin

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Pierre Yves Salaun

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Françoise Bodere-Kraeber

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

publication date

10 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

38

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

1064-1071

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

PET/CT for therapy response assessment in lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1741-0

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21308370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interim PET in lymphoma: a step towards standardization

1 reference

https://pubmed.ncbi.nlm.nih.gov/21308370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ABVD in the treatment of Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21308370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term cause-specific mortality of patients treated for Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21308370

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-011-1741-0

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21308370

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53245208&oldid=2246441764"